$8.880
-0.069 (-0.78%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
XLO-Prognose durch Analyse ähnlicher Charts
Alphio's XLO stock price prediction model matches the current Xilio Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.97 (+0.98%). The 1-week path is $8.54 (-3.78%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Xilio Therapeutics Inc-Aktien kaufen?
Xilio Therapeutics Inc is currently not a strong buy due to its recent performance and financial instability. The stock closed at $9.00, with a 5-day change of -2.49% and a year-to-date change of -4.29%. While there is potential for future growth, as indicated by a projected trajectory of +931.59%, the current RSI of 30.047 suggests the stock is oversold, which could indicate a potential rebound. However, the main risk is the negative net income reported for Q1 2026 at -$9.5 million, which reflects ongoing financial challenges.
XLO schloss am Tuesday bei $8.88, nachdem der Kurs -0.78% fallen
Xilio Therapeutics Inc (XLO) last closed at $8.88, losing -0.78%. These facts feed the 1-day and 1-week XLO price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Xilio Therapeutics Inc (XLO) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf XLO am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für XLO
Historically the probability of a positive September return for XLO is 47.62%. January offers the highest probability of a positive month at 55.74%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.